Mathias Jucker

University of Tuebingen, Germany, Tübingen, Baden-Württemberg, Germany 
"Mathias Jucker"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kim B, Dabin LC, Tate MD, et al. (2024) Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis. Nature Communications. 15: 3996
Levin J, Baiardi S, Quadalti C, et al. (2024) α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Parvin F, Haglund S, Wegenast-Braun B, et al. (2024) Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and Mice. Acs Chemical Neuroscience
Wisch JK, McKay NS, Boerwinkle AH, et al. (2024) Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 23: 500-510
Millar PR, Gordon BA, Wisch JK, et al. (2023) Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease. Molecular Neurodegeneration. 18: 98
Tu JC, Millar PR, Strain JF, et al. (2023) Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease. Biorxiv : the Preprint Server For Biology
Jucker M, Walker LC. (2023) Alzheimer's disease: From immunotherapy to immunoprevention. Cell. 186: 4260-4270
Johnson ECB, Bian S, Haque RU, et al. (2023) Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease. Nature Medicine
Lerouge F, Ong E, Rositi H, et al. (2023) targeting and multimodal imaging of cerebral amyloid-β aggregates using hybrid GdF nanoparticles. Nanomedicine (London, England)
Brosseron F, Maass A, Kleineidam L, et al. (2023) Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study. Alzheimer's Research & Therapy. 15: 13
See more...